Kolon Life Science Inc (102940) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Based on the latest financial reports, Kolon Life Science Inc (102940) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.58 Billion ≈ $1.75 Million USD) by net assets (₩346.41 Billion ≈ $234.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kolon Life Science Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Kolon Life Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 102940 total debt and obligations for a breakdown of total debt and financial obligations.

Kolon Life Science Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kolon Life Science Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beijing Transtrue Technology Inc SHE:002771	0.002x
Dalian Zhiyun Automation Co Ltd SHE:300097	0.049x
China Datang Corporation Renewable Power Co. Limited F:DT7	0.045x
EVS Broadcast Equipment SA BR:EVS	-0.014x
Beta Bionics, Inc. Common Stock NASDAQ:BBNX	-0.030x
Binh Minh Plastics JSC VN:BMP	-0.034x
Hota Industrial Mfg. Co Ltd TW:1536	0.026x
Calavo Growers Inc NASDAQ:CVGW	0.011x

Annual Cash Flow Conversion Efficiency for Kolon Life Science Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Kolon Life Science Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Kolon Life Science Inc market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩149.34 Billion ≈ $101.20 Million	₩-14.08 Billion ≈ $-9.55 Million	-0.094x	+47.78%
2023-12-31	₩137.67 Billion ≈ $93.30 Million	₩-24.87 Billion ≈ $-16.85 Million	-0.181x	-45.27%
2022-12-31	₩167.72 Billion ≈ $113.66 Million	₩-20.85 Billion ≈ $-14.13 Million	-0.124x	+23.64%
2021-12-31	₩99.41 Billion ≈ $67.37 Million	₩-16.19 Billion ≈ $-10.97 Million	-0.163x	-29.16%
2020-12-31	₩57.96 Billion ≈ $39.28 Million	₩-7.31 Billion ≈ $-4.95 Million	-0.126x	+36.89%
2019-12-31	₩101.02 Billion ≈ $68.46 Million	₩-20.18 Billion ≈ $-13.68 Million	-0.200x	-555.43%
2018-12-31	₩446.15 Billion ≈ $302.35 Million	₩-13.60 Billion ≈ $-9.22 Million	-0.030x	-100.45%
2017-12-31	₩545.41 Billion ≈ $369.62 Million	₩-8.29 Billion ≈ $-5.62 Million	-0.015x	-114.05%
2016-12-31	₩259.79 Billion ≈ $176.05 Million	₩28.11 Billion ≈ $19.05 Million	0.108x	-29.56%
2015-12-31	₩135.44 Billion ≈ $91.79 Million	₩20.81 Billion ≈ $14.10 Million	0.154x	+72.96%
2014-12-31	₩136.17 Billion ≈ $92.28 Million	₩12.10 Billion ≈ $8.20 Million	0.089x	--

About Kolon Life Science Inc

KQ:102940 Korea Pharmaceuticals

Market Cap

$453.05 Million

₩668.52 Billion KRW

Market Cap Rank

#13062 Global

#428 in Korea

Share Price

₩58600.00

Change (1 day)

-3.30%

52-Week Range

₩24250.00 - ₩70800.00

All Time High

₩163572.85